Jyothy Labs Raises Buyback Price to Rs 240, Retains Rs 147 Crore Size

Jyothy Labs Limited has raised the price for its Rs 147 crore share buyback to Rs 240 per equity share from Rs 215, while reducing the maximum shares sought to 61.25 lakh from 68.37 lakh. The revision was approved by the Buyback Committee on November 9, 2026, before the November 11 record date.

Why did Jyothy Labs revise its buyback offer?

Jyothy Labs revised the offer price and share quantity while keeping the maximum cash outlay at about Rs 147 crore. The Buyback Committee approved the changes under Regulation 5(via) of the Securities and Exchange Board of India Buy-Back of Securities Regulations, 2018, at its meeting on November 9, 2026.

The revised offer sets a cash price of Rs 240 for each fully paid-up equity share with a face value of Re 1. The company will buy back no more than 61,25,000 shares, equivalent to up to 1.67% of its total paid-up equity share capital. The tender offer will be conducted on a proportionate basis.

The company had initially announced a buyback of up to 68,37,210 shares at Rs 215 each. That original share count represented 1.86% of outstanding equity shares as of March 31, 2026. At the initial terms, the aggregate consideration was capped at Rs 147,00,00,150.

The revised terms preserve the stated broad offer size but change the number of shares that can be accepted. The higher price means a lower maximum quantity can be bought within the same aggregate amount. The supplied disclosures do not state a separate reason for the Buyback Committee's decision to revise the terms.

What are the revised Jyothy Labs buyback terms?

Jyothy Labs will seek up to 61.25 lakh equity shares at Rs 240 each through the tender offer route. Eligible shareholders may tender shares according to the entitlement and process set out under the applicable buyback regulations and offer documents.

The board approved the initial buyback on November 4, 2026. A public announcement was dated November 5 and published on November 6 in Financial Express, Jansatta and Navshakti. The initial announcement stated that the offer would follow the Companies Act, 2013 and SEBI's buyback regulations.

The revision followed the public announcement but preceded the record date. This sequencing is relevant because the price and maximum share quantity were updated before eligible holders were determined on the stated record date.

Which shareholders can participate in the tender offer?

Shareholders recorded as holders of Jyothy Labs shares on November 11, 2026 are eligible to participate in the buyback, subject to the detailed offer process. The company fixed November 11 as the record date to determine entitlements and the names of eligible shareholders.

The initial public announcement said the tendering period would begin on November 17, 2026 and remain open for five working days until November 23, 2026. These dates were disclosed in the original announcement. The supplied revision details change the price and share quantity, but do not identify any revised tendering dates.

Buybacks through the tender route are conducted on a proportionate basis, rather than being open-market repurchases. As a result, tendering shares does not by itself establish that all tendered shares will be accepted. Acceptance depends on entitlement, valid tenders and the final participation level under the prescribed process.

Shareholders seeking a physical Letter of Offer may request one from Jyothy Labs or MUFG Intime India Private Limited, the registrar referred to in the public announcement. The Letter of Offer is expected to set out the operational process and documentation required for participation.

How does the price revision affect investors and the market?

The Rs 240 offer price is Rs 25 higher than the original Rs 215 price, an increase of about 11.6%. A source cited the market price at Rs 200.75 on November 9, 2026, which placed the revised buyback price Rs 39.25, or about 19.6%, above that quoted level.

This comparison is only a price reference, not a measure of return from participating in the buyback. Under a proportionate tender offer, investors must consider the number of shares they may be entitled to tender and the possibility that only part of their tender may be accepted.

For the company, the disclosed maximum deployment remains Rs 147 crore despite the price change. The revision reduces the potential reduction in outstanding shares from 1.86% to 1.67% of paid-up equity capital. It therefore retains the cash cap while limiting the maximum number of shares that can be extinguished.

The offer was announced alongside Jyothy Labs' unaudited financial results for the quarter and half-year ended September 30, 2026. However, the provided material does not give financial-result figures or connect the buyback decision to any specific earnings, cash-flow or operating metric.

What is the regulatory and operating context for this buyback?

Jyothy Labs is undertaking the repurchase under the tender-offer framework of the Companies Act and the SEBI Buyback Regulations. This framework requires a record date, a public announcement and a Letter of Offer, with the process designed to identify eligible shareholders and govern tender acceptance.

The Buyback Committee's November 9 approval specifically used the provision allowing revisions to an announced buyback. The company informed BSE Limited, where it is listed under code 532926, and the National Stock Exchange of India Limited, where its symbol is JYOTHYLAB, about the revised proposal.

For retail investors, the key practical distinction is between holding eligibility and actual acceptance. Holdings as of the record date determine eligibility, while the final number of accepted shares is governed by entitlement and the tender process. The supplied material does not disclose the entitlement ratio.

The company has described the consideration as payable in cash. Beyond the buyback amount, price, maximum quantity, record date and original tender-window disclosure, the source does not provide further information on funding, cancellation of shares, or post-buyback share capital.

Conclusion

Jyothy Labs has retained a Rs 147 crore ceiling for its buyback while increasing the tender price to Rs 240 per share and cutting the maximum quantity to 61.25 lakh shares. The amendment raises the stated price available to eligible shareholders but reduces the proportion of equity that may be repurchased to 1.67%.

Investors should watch for the Letter of Offer and any exchange communication confirming the operative tender schedule, entitlement ratio and procedural instructions. The stated record date is November 11, 2026, while the original announcement identified November 17 to November 23, 2026 as the tendering period.